Maintenance outage: This site will be inaccessible from late evening Mar 7th thru Mar 8th. This is for scheduled technology upgrades by our global hosting service that are affecting numerous websites and online journals. Note that our submission site is still accessible during this period and processing of new submissions will not be affected.
  Follow this preprint

Vaccine effectiveness against SARS-CoV-2 infection with the Omicron or Delta variants following a two-dose or booster BNT162b2 or mRNA-1273 vaccination series: A Danish cohort study

Christian Holm Hansen, Astrid Blicher Schelde, Ida Rask Moustsen-Helm, Hanne-Dorthe Emborg, Tyra Grove Krause, Kåre Mølbak, Palle Valentiner-Branth on behalf of the Infectious Disease Preparedness Group at Statens Serum Institut
doi: https://doi.org/10.1101/2021.12.20.21267966
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.

Article Information

doi 
https://doi.org/10.1101/2021.12.20.21267966
History 
  • December 23, 2021.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Christian Holm Hansen, PhD*,1,
  2. Astrid Blicher Schelde, PhD*,1,
  3. Ida Rask Moustsen-Helm, PhD1,
  4. Hanne-Dorthe Emborg, PhD1,
  5. Tyra Grove Krause, PhD2,
  6. Kåre Mølbak2, DMSc,
  7. Palle Valentiner-Branth, PhD1,# and
  8. on behalf of the Infectious Disease Preparedness Group at Statens Serum Institut
  1. 1Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark
  2. 2Epidemiological Infectious Diseases Preparedness Statens Serum Institut, Copenhagen, Denmark
  1. ↵#Correspondence:
    Palle Valentiner-Branth, Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, 2300 Copenhagen, Denmark, pvb{at}ssi.dk

  1. ↵* contributed equally

Back to top
Posted December 23, 2021.
Download PDF
Print/Save Options
Download PDFFull Text & In-line FiguresXML
Data/Code
Email
Vaccine effectiveness against SARS-CoV-2 infection with the Omicron or Delta variants following a two-dose or booster BNT162b2 or mRNA-1273 vaccination series: A Danish cohort study
Christian Holm Hansen, Astrid Blicher Schelde, Ida Rask Moustsen-Helm, Hanne-Dorthe Emborg, Tyra Grove Krause, Kåre Mølbak, Palle Valentiner-Branth
medRxiv 2021.12.20.21267966; doi: https://doi.org/10.1101/2021.12.20.21267966
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area

Reviews and Context

114

Comment

0

TRIP Peer Reviews

0

Community Reviews

0

Automated Services

77

Blogs/Media

0

Author Videos

You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the medRxiv Alerts Page.

Sign In to Follow this Preprint

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.